Abstract. Previous studies have shown that highly sulfated Ï-carrageenan oligosaccharides (Ï-CO) possess an antiangiogenetic effect, while high concentrations of Ï-CO present a cytotoxic effect towards human umbilical vein endothelial cells (HUVECs). The aim of this study was to explore the underlying mechanism of Ï-CO on inhibiting cell proliferation. Ï-CO elicited reactive oxygen species (ROS) production with concentrations at 0.8 and 1 mg/ml, and this event was accompanied by the increase of early apoptotic cells, nuclear morphology changes and cell cycle arrest at the S and G 2 /M phases. However, prevention of oxidative stress by N-acetyl-L-cysteine (NAC) could abolish the effect of Ï-CO on these events. Yet, Ï-CO induced a depolarization of mitochondrial transmembrane potential. At 0.8 mg/ml, Ï-CO induced up-regulation of p53 and Bax, down-regulation of Bcl-2 and activation of caspase-9 and -3. These results suggest that exposure to a high concentration of Ï-CO activates the mitochondrial-mediated apoptotic pathway and cell cycle arrest by generation of ROS.
Introduction
Carrageenans are high molecular weight, sulfated polygalactans derived from several species of red seaweeds. The most common forms of carrageenan are Ï, κ, and È (1). Ï-carrageenan has a characterized structure. It contains alternating disaccharide units composed of D-galactose-2-sulfate and D-galactose-2,6-disulfate (2) . Since Ï-carrageenan contains a high degree of sulfate substitution in its structure (35% ester sulfate content), it has been found to show biological activities such as antitumor, immunomodulation (3) and antiviral (4) and inhibiting tumor metastasis (5) , especially the low molecular weight oligosaccharides. In our previous work, we also found that these oligosaccharides inhibit angiogenesis by blocking the endothelial cell invasion and migration at a relatively low concentration range (60-250 μg/ml) (6). However, Ï-carrageenan has long been used as a typical inflammatory agent for establishing inflammatory models, such as pain models, paw oedema, arthritis, pleurisy or ulceration. Some reports also suggest that the degraded carrageenan (poligeenan), which is manufactured by the deliberate acid hydrolysis of carrageenan at high temperature (>80˚C), is the prime cause for inducing ulceration (7, 8) . In our previous research, we observed that certain concentrations of Ï-carrageenan oligosaccharides (Ï-CO) (>250 μg/ml) inhibited cell survival, especially at a high concentration (>800 μg/ml) and the viability of human umbilical vein endothelial cells (HUVECs) was inhibited >50% (6) . Whether the high concentration of degraded Ï-CO will disturb their therapeutic potential and how these oligosaccharides exert their cytotoxic effect is worth evaluating.
Materials and methods
Materials. Ï-CO were self-prepared, as previously reported (6) . JC-1(5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide), N-acetyl-Lcysteine (NAC), 2',7'-dichlorofluorescein diacetate (DCFH-DA), Hoechst 33258 were obtained from Sigma (Shanghai, China). Annexin V-FITC apoptosis detection kit, Cycle Test™ Plus DNA reagent kit and FITC-conjugated monoclonal active caspase-3 antibody apoptosis kit were purchased from BD Biosciences Pharmingen (San Jose, CA, USA). CaspaTag™ caspase-9 in situ assay kit was purchased from Chemicon International, Inc. (Billerica, MA, USA). Mouse monoclonal antibodies specific for Bcl-2 (1:300) and ß-actin (1:1,000), rabbit polyclonal antibodies specific for Bax (1:400) and p53 (1:500), horseradish peroxidase-conjugated goat anti-mouse or anti-rabbit secondary antibody (1:2,000) and ECL detection kit were obtained from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). HUVECs treated with/without Ï-CO were incubated with 2.5 μg/ml JC-1 in the dark for 20 min at 37˚C. Cells were washed twice in PBS, resuspended in 400 μl PBS and analyzed by flow cytometry. A 488-nm filter was used for excitation of JC-1. Emission filter of 535 and 595 nm were used to quantify the population of HUVECs with green (JC-1 monomer) and orange (JC-1 aggregates) fluorescence, respectively. The percentage of the population stained green (FL-1) and orange (FL-2) were measured by histograms. In addition, all samples were observed by fluorescence microscopy to confirm JC-1 labeling patterns.
Ï-
Western blot analysis. Cells treated with 0.8 mg/ml Ï-CO for 0, 12, 24, 36 h were harvested and lysed in 200 μl ice-cold lysis buffer. The soluble protein concentrations were determined by BCA assay. Protein was subjected to SDS-PAGE and transferred to a PVDF membrane. After blocking with 5% nonfat milk, the membrane was incubated overnight at 4˚C with primary antibodies (anti-Bcl-2, anti-Bax and anti-p53 antibody). After washing, blots were incubated with HRPconjugated secondary antibody. Chemiluminescence was used to visualize the bands. The net intensity of bands was calculated to analyze the relative content of Bcl-2, Bax, and p53.
Active caspase-9 detection. The activities of caspase-9 were measured by CaspaTag™ caspase-9 in situ assay kit. According to the manufacturer's instruction, harvested cells treated with or without Ï-CO were incubated with 10 μl of freshly prepared FLICA reagent for 1 h at 37˚C in 5% CO 2 in the dark. Then, cells were washed twice in PBS, resuspended in 400 μl wash buffer and analyzed by flow cytometry.
Active caspase-3 detection. Caspase-3 activity was detected by using FITC-conjugated monoclonal active caspase-3 antibody apoptosis kit. Cells at a concentration of 1x10 6 cells/ml were incubated with FITC-conjugated caspase-3 antibody (10 μg/ml) for 20 min in the dark and rinsed twice in PBS. Cells were measured by flow cytometry after resuspended in 1 ml of PBS.
Statistical analysis. Data were expressed as means ± standard deviation (SD) of three separate experiments. Significance of differences among groups was determined using Student's t-test. Statistical significance was defined as P<0.05.
Results

Effects of Ï-CO on intracellular ROS level.
In our previous studies, we found that high concentrations of Ï-CO showed an inhibitive growth effect on HUVECs (at 1 mg/ml, the inhibitory ratio reached upto 60.23%) (6) . Considering that oxidative stress is an important factor in causing cell death (10) and hyperglycaemia also elicits oxidative stress in cells (11) we firstly explored the effects of Ï-CO on the accumulation of intracellular ROS using the fluorescent probe DCFH-DA. The results show that incubation with Ï-CO for 24 h leads to a remarkable increase in intracellular ROS compared with control. At a dose of 0.8 and 1.0 mg/ml Ï-CO, intracellular ROS levels were 11.4 and 13.2 times that of the control group, respectively (Fig. 1) . The addition of a known antioxidant N-acetylcysteine largely blocked the production of ROS, which reveals that Ï-CO treatment can trigger ROS production.
Dose response of Ï-CO-induced apoptosis and effect of NAC on Ï-CO-induced apoptosis.
Apoptosis was analyzed by annexin V assay, which detects the arrangement of phosphatidylserine from the inner to the outer plasma membrane leaflet during early stages of apoptosis (12) . The increase in the number of apoptitic cells is shown in Fig. 2 . Treatment of HUVECs with 0.8 and 1.0 mg/ml Ï-CO for 24 h induced a dose-dependent increase in the percentage of apoptotic cells compared with controls. At 1.0 mg/ml, 41.11% of cells were apoptotic. Interestingly, we observed that Ï-CO-induced apoptosis was remarkably abolished by pretreatment with NAC. The apoptotic ratios decreased to 1.14±0.78 and 1.52±0.92% (Fig. 2d and e) . This result clearly confirms that ROS production is the pivotal process in Ï-CO-induced HUVEC apoptosis.
To further explore whether the apoptotic effect of Ï-CO influences the morphology of cell nuclei, the changes of nuclear features were detected by Hoechst 33258 (Fig. 3) . Visualization of fluorescence revealed typical chromatin condensation after 0.8 mg/ml Ï-CO treatment. When HUVECs were treated with 1 mg/ml Ï-CO, the margination in some cells and apoptotic body-like structures appeared, which indicates that Ï-CO-induced apoptosis of HUVECs eventually resulted in the fragmentation of nuclei.
Effect of Ï-CO on cell cycle distribution of HUVECs. FACS analysis was performed to determine the effect of Ï-CO on cell cycle. Ï-CO induced the increase of cells in the S and G 2 /M phase, concomitant with a decrease in G 0 /G 1 in a dosedependent manner, especially the high dose of 1 mg/ml Ï-CO improved the population of cells in G 2 /M by~25% (Table I ). Yet, the cells accumulated in the S phase do not suggest that Ï-CO induces S phase arrest because cells in this phase could have entered the G 2 /M partly to increase G 2 /M content. In contrast, the decrease of G 0 /G 1 population revealed obviously that the G 2 /M phase was arrested. These results suggest that Ï-CO treatment prevented or slowed down the synthesis of DNA, and the G 2 /M checkpoint blocked the entry of cells into mitosis when DNA was damaged. However, pretreated with Figure 2 . Apoptosis detection in HUVECs using the annexin V assay. Cells were exposed to (a) vehicle; (b) 0.8 mg/ml Ï-CO; (c) 1 mg/ml Ï-CO; (d) 0.8 mg/ml Ï-CO+10 mmol/l NAC; (e) 1 mg/ml Ï-CO+10 mmol/l NAC. Apoptotic cells were determined after 24 h. Cells per treatment condition (10,000) were analyzed by flow cytometry. In each plot, the Annexin V-FITC + /PI -denotes early apoptotic cells (lower right quadrant). Table I . Effect of Ï-CO on cell cycle distribution in HUVECs (%).
- NAC profoundly reduced the percentage of cells in the S and G 2 /M phases, which indicates that the antioxidant property of NAC repairs DNA damage triggered by Ï-CO, or stops Ï-CO from injuring DNA. Interestingly, we observed a marked increase of G 1 population after the addition of NAC, and this result was also found by Menon et al, who reported that NAC inhibits cell progression from G1 to S phase, causing G1 arrest (13) .
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Effects of Ï-CO on MMP.
The loss of MMP (Δ"m) is a hallmark for apoptosis. Tan et al suggested that the mitochondrial electron transport chain is a major source of cellular ROS (14) . To determine whether Ï-CO-induced apoptosis involves the disruption of integrity of the mitochondrial membrane, MMP was measured using JC-1. Fig. 4 shows fluorescence microscopy of JC-1 staining of HUVECs with or without Ï-CO treatment. High mitochondrial polarization is indicated by red fluorescence and depolarized regions are indicated by green fluorescence (15) . In Fig. 4a , most cells without Ï-CO treatment show red fluorescence in mitochondrion, indicating integrity of the mitochondrial membrane. However, Ï-CO treatment induced perturbation in the function of the mitochondrial membrane, as indicated by the red to green color switch in a great number of HUVECs. Flow cytometry quantitative analysis performed on cells after JC-1 labeling, clearly shows that Ï-CO induced alteration in the mitochondrial membrane 2.7-fold compared with untreated cultures (Fig. 4B) . Therefore, these results indicate that Ï-CO treatment induce the disruption of integrity of mitochondrial membrane in HUVECs, which may subsequently involve the release of ROS and eventually induce apoptosis of cells.
Effects of Ï-CO on the expression and activation of apoptoticrelated proteins.
The protein expression of some apoptosis associated genes, including Bcl-2, Bax and p53 were measured with the aim of assessing possible involvement of Ï-CO in mitochondrial-mediated apoptosis. p53 is crucial to the apoptotic pathway which is found to trigger programmed cell death in response to DNA damage (16) . Results from Western blotting show that after treated with Ï-CO, level of p53 expression was up-regulated (Fig. 5) . In control group, p53 level was low and undetectable, while Ï-CO induced a timedependent accumulation of p53. Since p53, in response to cellular stress, has been linked to mitochondrial-mediated apoptosis by the transcriptional activation of its target genes, including pro-apoptotic Bax gene and anti-apoptotic Bcl-2, we examined the expression of these two proteins. The significant decrease of Bcl-2 and increase of Bax protein were achieved from 12 to 36 h. We measured the optical density of these bands and found that the Bcl-2/Bax ratio decreased. After 36 h treatment of Ï-CO, the ratio of Bcl-2/Bax expression decreased ~3-fold compared with the control group (Fig. 5B) .
With the mitochondrial membrane potential destroyed by ROS, the permeability transition pore will open and intermembrane proteins are released from the mitochondria, which in turn activates the downstream caspase-9 (17). The level of active caspase-9 was detected by flow cytometry. Results show that cells with active caspase-9 increased significantly after treatment with Ï-CO (Fig. 6) . Cells with positive active caspase-9 were 33.24±4.62 and 71.10±4.89% for 0.8 and 1.0 mg/ml Ï-CO treatment, respectively. Caspase-3 is one of the key executioners of apoptosis (18) . After treated with Ï-CO for 24 and 48 h, HUVECs with activated caspase-3 were increased from only 0.87±0.4 and 0.97±0.5% in the control group to 6.30±0.9 and 24.39±1.6% in the 1 mg/ml group (Fig. 7) . Collectively, these results suggest that exposure of Ï-CO led to the activation of the mitochondria-mediated apoptotic pathway including up-regulation of Bax, downregulation of the Bcl-2 gene associated with activation of caspase-9 and -3.
Discussion
Considering our previous studies, Ï-carrageenan with a molecular weight of ~3,350 showed anti-angiogenesis activity at a low concentration (<250 μg/ml). At a high concentration from 0.5 to 1 mg/ml, Ï-CO exhibited an inhibitive effect on the proliferation of HUVECs. The question is, whether this kind of cell death will disturb or assist the application of Ï-CO as an anti-angiogenesis agent. We performed this study in order to clarify the precise molecular mechanism involved in the inhibitory effect of Ï-carrageenan on cell proliferation. Our results clearly show that treatment of HUVECs with Ï-CO elicited the production of ROS, evidenced by DCFH-DA fluorometric assay. The generated ROS may play a role in the inhibition of cell proliferation and the inducement of apoptosis in HUVECs. Quenching ROS by NAC, an oxidant scavenger, not only suppressed the ROS generation, but also largely reversed the apoptosis caused by Ï-CO. On the other hand, ROS may lead to free radical attack of membrane phospholipids and loss of MMP (19) , inducing the activation of Bax, and active caspase-9, which ultimately activates the downstream caspase-3 (20, 21) . Caspase-3 activation led to DNA breakage and cell apoptosis. In our case, the apoptosis induced by Ï-CO perfectly tallied with this procedure since we observed the loss of mitochondrial transmembrane potential, down-regulation of Bcl-2, up-regulation of Bax and enhanced active caspase-9 and -3. Therefore, it is confirmed that Ï-COinduced cell death belongs to a typical mitochondrialmediated apoptotic pathway.
In the present study, HUVECs displayed an oxidative stress-induced cell cycle arrest. Ï-CO-promoted cells continued through to the G1 phase and accumulated at the S and G 2 /M phases. In contrast, cells coincubated with Ï-CO and NAC could go through the G 2 /M phase. These findings implicate that oxidative stress induced by Ï-CO controls the cell cycle by attacking DNA or influencing the DNA synthesis rate, and eventually arrests cells at the G 2 /M phase. We examined the mechanism of dysregulated cell cycle arrest in HUVECs. It was observed that the p53 protein was up-regulated after exposure to 0.8 mg/ml Ï-CO. In response to ROS-induced DNA damage, p53 may also guide corrupt cells into apoptosis through mitochondrial mediated pathway by inducing expression of proapoptotic protein Bax.
Our previous study revealed that Ï-CO exhibited antiangiogenesis efficacy at a concentration <250 μg/ml, while no cytotoxicity against HUVECs was observed (6). We believe Figure 6 . Levels of activated caspase-9. After treatment with 0.8 and 1 mg/ml Ï-CO for 24 or 48 h, activated caspase-9 was detected using a CaspaTag caspase-9 in situ assay kit and analyzed by flow cytometry. The representative histograms from three independent experiments are shown. * P<0.05, ** P<0.01 compared with control. Figure 7 . Levels of activated caspase-3. After treated with different concentrations of Ï-CO for 24 or 48 h, activated caspase-3 was detected using FITC-conjugated monoclonal active caspase-3 antibody apoptosis kit and analyzed by flow cytometry. The representative histograms from three independent experiments are shown. * P<0.05, ** P<0.01 compared with control. Figure 8 . Model for the mechanism of apoptosis induced by Ï-CO in HUVECs. Treatment of Ï-CO elicits the initial generation of ROS which impairs mitochondrial function and destroys mitochondrial integrity. The loss of mitochondrial membrane potential may induce the cell mitochondria-mediated molecular pathway of apoptosis, observed as increasing level of Bax and decreasing level of Bcl-2. Then the release of intermembrane proteins such as cytochrome c will interact with Apaf-1 to activate caspase-9 and ultimately activates downstream caspase-3. Caspase-3 activation led to DNA breakage, nuclear chromatin condensation, and cell apoptosis. As a consequence, nuclear lamins are cleaved, leading to apoptosis.
that the anti-proliferation effect of high doses of Ï-CO cooperates in reducing the proliferation of a network of blood vessels by promoting the apoptosis of vascular endothelial cells since in tumor tissue the vascular endothelial cells have abnormal growth (22) . Taken together, our study indicates that ROS mediates apoptosis in HUVECs caused by Ï-CO, and that the mitochondria pathway is involved. Based on the results obtained to date, our working hypothesis (Fig. 8) is that the Ï-CO triggered the generation of intracellular ROS, and the accumulation of ROS is an initiator of apoptosis by upregulating the expression of p53, which induced the decrease of MMP, and caused downstream caspase activation (including caspase-9 and -3).
